Breathing Machines MarketDynamics
Increasing number of respiratorydisorders such as asthma and COPD, and rising number of surgeries are expectedto drive growth of the global BreathingMachines Market. According to the National Institute of Health data of2014, asthma affects over 24 million people in the U.S., including over 6million children. Breathing problems can also occur due to serious conditionssuch as pneumonia, tuberculosis, lung cancer, and other lung diseases. Accordingto the World Health Organization (WHO) estimates, by 2030, the four majorpotentially fatal respiratory diseases including COPD, pneumonia, lung cancer,and tuberculosis will account for around one in five deaths worldwide.
Millions of people in the U.S.suffer from breathing problems such as chronic obstructive pulmonary disease(COPD), which includes chronic bronchitis and emphysema. COPD is a progressivelife-threatening lung disease that causes breathlessness and predisposes toexacerbations and serious illness. In 2016, the Global Burden of Diseasereported a prevalence of around 251 million cases of COPD worldwide. Accordingto the same source, a total of 3.17 million deaths occurred due to COPD in2015, which account for 5% of all deaths globally. COPD prevalence is expectedto increase in the near future due to higher smoking prevalence and agingpopulations in many economies worldwide.
However, few drawbacks ofbreathing machines include throat discomfort, damage to vocal cords, andsleeping discomfort. Some complications of using a breathing machine mayinclude lung damage, collapsed lung, pneumonia or infection. Moreover, constantmedical care is required when a breathing machine is used. These factors areexpected to hinder growth of the market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2032
Breathing machine helps thepatient to breathe while they are suffering from chronic respiratory diseasesor unable to breathe by themselves after anesthesia. Breathing machines areused during surgeries that require general anesthesia, as the medicines used toinduce anesthesia can disrupt normal breathing. The machine is required afterthe surgery, as the patient may not be able to breathe immediately after theprocedure. The type of breathing machine used varies according to the problem.
Ventilators are mainly used inemergency medicine, home care, intensive care medicine, and in anesthesia, as acomponent of an anesthesia machine. The oxygen concentrator delivers pureoxygen via a mask or nasal cannula. It may be used in hyperbaric chambers andoxygen therapy. A C-PAP (continuous positive airway pressure) breathing machineblows air into the nose through a mask, which in turn keeps the airway open andhelps in the absorption of oxygen.
Nebulizers are generally used forthe treatment of a range of respiratory disorders such as chronic obstructivepulmonary disease (COPD) and asthma. Medications are inhaled straight into thelungs for effective treatment. These machines aid people who suffer from asthmaby delivering liquid medication through a mist, which is inhaled into the lungsvia machine. These devices are majorly used in home care settings.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/breathing-machines-market-2032
Breathing Machines MarketRegional Insights
On the basis of region, theglobal breathing machines market is segmented into North America, LatinAmerica, Europe, Asia Pacific, Middle East, and Africa. North America isexpected to hold dominant position in the global breathing machines market interms of revenue share, owing to increasing number of patients receivingtreatments for respiratory diseases. According to COPD International, in 2016,around 12 million people in the U.S. were suffering from COPD and an estimated12 million more were undiagnosed. According to a Centers for Disease Controland Prevention (CDC) report, it is the fourth leading cause of death in theU.S.
Asia Pacific breathing machinesmarket is expected to exhibit highest CAGR, owing to continuously increasingnumber of surgeries and respiratory disease burden in the region. For instance,according to WHO 2017 report, over 90% of COPD deaths occur in low andmiddle-income economies. The primary cause of COPD is exposure to tobaccosmoke. Other risk factors include exposure to indoor and outdoor air pollutionand occupational fumes and dusts.
Breathing Machines Market:Competitive Landscape
Key players operating in theglobal breathing machines market include BD, Drager Medical, Fisher &Paykel, GE Healthcare, Invacare, Maque, Medtronic, OMRON, Philips Healthcare,Teijin Pharma Resmed, and Weinmann. Key players are focusing on improvingbreathing machines by developing energy-efficient power systems and productfeatures such as lightweight maneuverability, long-lasting components, andpatient-friendly design.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2032
AboutCoherent Market Insights:
Coherent MarketInsights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
